Agentic AI development services for life sciences
Move beyond LLM experiments. Put reliable AI agents to work across R&D.
The barrier is not access to another LLM. It is making agentic work dependable.
Research and data teams are being asked to automate multi-source scientific work: synthesizing literature, curating metadata, harmonizing data, ranking hypotheses and generating reports. Yet a promising proof of concept can stall when it meets proprietary data, complex infrastructure and the need for scientific accountability.
Without the right architecture and controls, teams face five practical risks:
Results that lack transparency
A confident answer is not evidence that the answer – or the reasoning behind it – is reliable.
Uncontrolled cost
Agents can repeat steps, fetch too much data or consume unnecessary tokens.
Data and security exposure
Autonomous access must be constrained by permissions, approved tools and deployment boundaries.
Weak evaluation
Teams need to know where a system works, where it fails and whether performance changes over time.
Low scientific adoption
Researchers will not rely on a system they cannot challenge, inspect or fit into their daily work.
We translate a defined research or data process into an agentic workflow. Specialized agents divide complex work, use approved data and tools, and coordinate through planned steps rather than forcing one model to handle everything. Grounding, evaluation and human approvals are designed into the workflow so teams can inspect outputs and retain control over consequential decisions.
The result is not an off-the-shelf “ChatGPT for pharma.” It is a purpose-built system connected to the environment in which your teams already work – designed to automate repeatable steps, support scientific analysis and make the path from question to output easier to review.
Agentic AI for life sciences
Benefit pilars
Make outputs easier to verify
Ground outputs in approved knowledge and retain references so scientists can inspect the evidence behind each answer.
Put agents to work across your actual R&D environment
Connect agents to LIMS, ELNs, databases and pipelines through workflow-specific, MCP-based integration.
Control operational risk and cost
Use permissions, guardrails and monitoring to limit unintended actions, unnecessary loops and avoidable model use.
Automate repeatable scientific and data work
Reduce manual synthesis, reporting, annotation and data processing while keeping experts in the review loop.
Build for adoption, not just demonstration
Fit the interaction, terminology and controls to scientists’ daily work so outputs are easier to challenge and use.
Proven across complex agentic workflows
A life-sciences engineering partner for the work between prototype and trusted use
Ardigen brings together agentic-system engineering, biomedical data context and workflow integration. That combination matters when the system must work across scientific data, enterprise tools and human decision-making.
Evaluation is part of the architecture
Benchmark the system on your data and tasks, identify failure modes and monitor behavior over time.
Agents are specialized by role
Divide complex work across coordinated agents instead of overloading a single model.
Integration reaches the tools where work happens
Connect agents directly to approved data, applications and pipelines through MCP-based interfaces
Grounding supports scientific scrutiny.
Ground outputs in approved sources and retain references so scientists can inspect the evidence behind each answer.
Human oversight stays explicit
Define approval points, guardrails and terminology controls around the workflow.
Knowledge graphs connect scientific context
Give agents structured access to relationships across biomedical entities, internal data and supporting evidence. Explore knowledge graph operationalization.
Frequently Asked Questions
What is an agentic AI system in pharmaceutical R&D?
It is a purpose-built system in which specialized AI agents coordinate tasks, use approved data and tools, and review intermediate work to complete a defined R&D workflow. Unlike a standalone chatbot, it is designed around the scientific process, integration requirements, and human decision points. We recommend the article that explains:
How can AI agents connect with LIMS, ELNs, and proprietary research databases?
Ardigen can connect agents through MCP-based interfaces and other approved integration methods. Each agent receives role-specific access to the data, applications, and actions required for its task, subject to the capabilities and permissions of the source systems.
How does Ardigen evaluate a multiagent AI workflow?
Ardigen defines success criteria for the target workflow, then tests the system on relevant tasks, data, and edge cases. Evaluation examines output quality, references, failure modes, agent behavior, and resource use so the workflow can be monitored and improved.
How are human review and approval incorporated into an AI research co-pilot?
Human review points are built into the workflow wherever expert judgment or authorization is required. Scientists can inspect supporting sources, challenge outputs, and approve consequential steps rather than handing decisions to the system by default.
Can an agentic AI system be deployed within our existing cloud or VPC environment?
Ardigen can design agentic systems for deployment within an existing cloud or VPC environment, subject to the organization’s infrastructure and security requirements. Access controls, logging, and data-protection measures are defined with the relevant technical and security teams for each engagement.
Which pharma and biotech workflows are suitable for an AI research co-pilot?
Strong candidates are repeatable, multi-step workflows that depend on several data sources or tools and still require expert review. Examples include literature synthesis, metadata or gene annotation, data ingestion and FAIRification, research reporting, agentic data analysis, and hypothesis or target-ranking support.
Build agentic AI workflows your scientists can test, trace and trust.
See the impact
Case studies
See also:
Contact
Ready to transform drug discovery? Partner with Ardigen
Leave us a message and we will reach out to you within 24 hours, to tell you more about how we can empower your drug development journey.
Newsletter
Become an insider
Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!